• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RNA

RNA

Atrium Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD12.17

-0.08 (-0.65%)

Rating:C+

Company Profile

CEO

Kathleen Gallagher

IPO Date

2026-02-27

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$12.27

Prev. Close

$12.25

Day Low

$12.12

Day High

$12.39

52W Low

$11.95

52W High

$16.77

Market Cap

$0.21B

Volume

0.15M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

5

Avg Positive

37.0%

Avg Negative

1.0%

Avg Neutral

62.0%

News Feed

Avidity Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights

PRNewsWire·5/12/2021·↑ positive

Avidity Biosciences to Host Virtual Investor and Analyst Event on May 19, 2021

PRNewsWire·5/3/2021·↑ positive

Avidity Biosciences to Participate in Upcoming Investor Conferences

PRNewsWire·3/25/2021·↑ positive

Avidity Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Highlights

PRNewsWire·3/15/2021·↑ positive

Avidity Biosciences Announces Addition to the Nasdaq Biotechnology Index

PRNewsWire·12/21/2020·↑ positive